ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Perspective Therapeutics Inc

Perspective Therapeutics Inc (CATX)

2.73
-0.03
(-1.09%)
終了 2月25日 6:00AM
2.70
-0.03
(-1.10%)
取引時間後: 9:59AM
高度なチャート

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
2.73
買値
-
売値
-
出来高
923,414
2.36 日の範囲 2.79
2.70 52 週間の範囲 19.05
時価総額
前日終値
2.76
始値
2.79
最終取引時間
財務取引量
US$ 2,486,784
VWAP
2.693
平均取引量 (3 か月)
1,021,667
発行済株式数
67,587,540
配当利回り
-
PER
-3.97
1 株当たり利益 (EPS)
-0.69
歳入
1.43M
純利益
-46.51M

Perspective Therapeutics Inc について

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. 詳細を表示

セクター
Eating Places
業界
Surgical,med Instr,apparatus
ウェブサイト
本社
Wilmington, Delaware, USA
設立
1983
Perspective Therapeutics Inc is listed in the Eating Places sector of the アメリカ証券取引所 with ticker CATX. The last closing price for Perspective Therapeutics was US$2.76. Over the last year, Perspective Therapeutics shares have traded in a share price range of US$ 2.70 to US$ 19.05.

Perspective Therapeutics currently has 67,587,540 shares in issue. The market capitalisation of Perspective Therapeutics is US$186.54 million. Perspective Therapeutics has a price to earnings ratio (PE ratio) of -3.97.

CATX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.33-10.78431372553.063.112.74666312.86283237CS
4-1.25-31.40703517593.984.1152.76345233.37695668CS
12-1.62-37.24137931034.354.382.710216673.41788457CS
26-13.26-82.926829268315.9916.552.712107536.92372725CS
52-6.822-71.41959798999.55219.052.7245060112.29866234CS
156-1.033-27.45150146163.76319.052.05167239410.38005626CS
260-1.033-27.45150146163.76319.052.05167239410.38005626CS

CATX - Frequently Asked Questions (FAQ)

What is the current Perspective Therapeutics share price?
The current share price of Perspective Therapeutics is US$ 2.73
How many Perspective Therapeutics shares are in issue?
Perspective Therapeutics has 67,587,540 shares in issue
What is the market cap of Perspective Therapeutics?
The market capitalisation of Perspective Therapeutics is USD 186.54M
What is the 1 year trading range for Perspective Therapeutics share price?
Perspective Therapeutics has traded in the range of US$ 2.70 to US$ 19.05 during the past year
What is the PE ratio of Perspective Therapeutics?
The price to earnings ratio of Perspective Therapeutics is -3.97
What is the cash to sales ratio of Perspective Therapeutics?
The cash to sales ratio of Perspective Therapeutics is 128.77
What is the reporting currency for Perspective Therapeutics?
Perspective Therapeutics reports financial results in USD
What is the latest annual turnover for Perspective Therapeutics?
The latest annual turnover of Perspective Therapeutics is USD 1.43M
What is the latest annual profit for Perspective Therapeutics?
The latest annual profit of Perspective Therapeutics is USD -46.51M
What is the registered address of Perspective Therapeutics?
The registered address for Perspective Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Perspective Therapeutics website address?
The website address for Perspective Therapeutics is perspectivetherapeutics.com
Which industry sector does Perspective Therapeutics operate in?
Perspective Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ATCHAtlasClear Holdings Inc
US$ 5.53
(135.32%)
146.44M
DXFEason Technology Limited
US$ 13.3899
(33.63%)
84.79k
ITPIT Tech Packaging Inc
US$ 0.425
(21.43%)
3.26M
CPHIChina Pharma Holdings Inc
US$ 0.2519
(21.11%)
8.52M
GPUSHyperscale Data Inc
US$ 3.57
(15.16%)
90.89k
AEONAEON Biopharma Inc
US$ 0.0675
(-43.89%)
13.14M
SOARVolato Group Inc
US$ 2.569
(-31.49%)
305.7k
BURUNuburu Inc
US$ 0.2046
(-28.96%)
22.31M
UMACUnusual Machines Inc
US$ 8.375
(-18.05%)
1.63M
SATXSatixFy Communications Ltd
US$ 1.15
(-17.27%)
197.58k
ATCHAtlasClear Holdings Inc
US$ 5.53
(135.32%)
146.44M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.01
(1.35%)
84.04M
FXIiShares China Large Cap
US$ 35.055
(-3.27%)
83.97M
FOXOFOXO Technologies Inc
US$ 0.202
(-1.46%)
82.58M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 3.29
(4.28%)
77.76M

CATX 財務

財務

CATX Discussion

投稿を表示